Navigation Links
US Representative Mike Fitzpatrick Tours US BioDesign Manufacturing Facility

QUAKERTOWN, Pa., Sept. 6, 2013 /PRNewswire-iReach/ -- On August 28, Tom Molz, Founder and President of US BioDesign LLC, a premier supplier of implantable biomedical textile components to the global medical device industry, led civic and business leaders including US Representative Mike Fitzpatrick on a tour of the company's newly relocated offices and manufacturing facility in Quakertown, Pennsylvania. Congressman Fitzpatrick congratulated US BioDesign's commitment to expanding local manufacturing job opportunities. Pennsylvania Senator Bob Mensch also cited the company's commitment to manufacturing excellence and fostering regional economic growth.


The tour spotlighted US BioDesign's highly specialized capabilities, clean room technology and state-of-the-art manufacturing equipment, which includes the world's largest medical braider and custom-designed processes for non-woven medical felts. According to Mr. Molz, the facility expansion supports the company's business strategy for remaining competitive, despite the Affordable Care Act's economic impact on the global medical device industry.

"The Affordable Care Act mandates a 2.3% tax on the sale of medical devices which means our customers have to do more with less," said Keith Smith, Director of Business Development.  "Our streamlined approach to new product development enables the most cost effective use of resources, helping medical device companies address this challenge," he continued.

According to Mr. Molz, unlike some long established suppliers to the medical device industry, US BioDesign is a new company with an agile and flexible operating structure designed to support its singular founding mission: To serve the medical device industry as a highly capable, yet cost efficient supplier of engineered medical textiles, biomedical structures and implantable fabrics.  "Our business strategy," he said, "advances that mission and positions US BioDesign as the foremost industry resource for expert, highly reliable, highly capable, high quality yet cost efficient medical fabric development and manufacturing solutions."

"What you see is what you get - a smart, competitive company with an operating structure that's only as big as it needs to be, and agile and flexible enough to respond to changing industry dynamics without compromising quality or cost efficiency," commented Mr. Smith.

US BioDesign employees combine some 100 years of expertise in biomaterials and medical fabric design, development and manufacturing.  "The extensive medical device industry knowledge and expertise of our leadership and engineering teams can help medical device companies control R&D costs despite current and emerging economic challenges," said Mr. Molz.

US BioDesign Founder Tom Molz has driven discovery and innovation within the medical/biomedical textiles and implantable fabrics for medical devices industry for more than 20 years, and has been involved with biomedical textile developments in virtually all areas of the medical device industry. US BioDesign is the second biomedical manufacturing company founded by Mr. Molz.  Keith Smith brings extensive experience in bio-materials and textile structures used for implantable medical device components, in addition to leading business development and managing strategic client relationships for US BioDesign.

About US BioDesign

US BioDesign is a global leader in the development and manufacture of biomedical textile structures for medical devices across the cardiovascular, neurological and general surgery segments of the health care industry.   The company draws upon deep biomedical engineering expertise and an unparalleled understanding of medical device construct development involving polymeric and/or metallic raw materials to deliver elegant and efficient engineering solutions and commercial development support.  Founded in 2011, US BioDesign serves the global medical device industry, specializing in braided and non-woven components. 


US BioDesign LLC
Keith Smith, Director of Business Development
P: 267- 450-8860, x210

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
2. PCMA: 88 U.S. Representatives Urge USPS to Preserve Six Day Delivery of Mail-Service Pharmacy
3. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
4. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. US BioDesign Relocation Expands Manufacturing Capabilities
7. Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023
8. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
9. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
10. China Orthopedic Devices Market, Contract Manufacturing in Orthopedic Industry Reports
11. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):